Cover Image
市場調查報告書

Medestea Research & Production S.p.A.的產品平台分析

Medestea Research & Production S.p.A. - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 317361
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
Medestea Research & Production S.p.A.的產品平台分析 Medestea Research & Production S.p.A. - Product Pipeline Review - 2016
出版日期: 2016年09月30日 內容資訊: 英文 34 Pages
簡介

Medestea Research & Production S.p.A.是總公司位於義大利的製藥企業,提供發炎、腸胃疾病、心血管系統疾病、免疫調節、代謝疾病、呼吸疾病、罕見疾病等領域的新藥和細胞型治療藥等。

本報告提供Medestea Research & Production S.p.A.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Medestea Research & Production S.p.A.的基本資料

  • Medestea Research & Production S.p.A.概要
  • 主要資訊
  • 企業資料

Medestea Research & Production S.p.A.:R&D概要

  • 主要的治療範圍

Medestea Research & Production S.p.A.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Medestea Research & Production S.p.A.:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 臨床試驗前階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Medestea Research & Production S.p.A.:藥物簡介

  • Lysine Acetylsalicylate
  • AT-20
  • Adipose Tissue Derived Stem Cells
  • Deina
  • doxorubicin pegylated liposome
  • IAC VITA
  • MED-1101
  • Tribarcina
  • U-94
  • Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS

Medestea Research & Production S.p.A.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Medestea Research & Production S.p.A.:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08144CDB

Summary

Global Markets Direct's, 'Medestea Research & Production S.p.A. - Product Pipeline Review - 2016', provides an overview of the Medestea Research & Production S.p.A.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Medestea Research & Production S.p.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Medestea Research & Production S.p.A.
  • The report provides overview of Medestea Research & Production S.p.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Medestea Research & Production S.p.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Medestea Research & Production S.p.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Medestea Research & Production S.p.A.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Medestea Research & Production S.p.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Medestea Research & Production S.p.A.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Medestea Research & Production S.p.A. Snapshot
    • Medestea Research & Production S.p.A. Overview
    • Key Facts
  • Medestea Research & Production S.p.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Medestea Research & Production S.p.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Medestea Research & Production S.p.A. - Pipeline Products Glance
    • Medestea Research & Production S.p.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Medestea Research & Production S.p.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Medestea Research & Production S.p.A. - Drug Profiles
    • AT-20 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Deina - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • doxorubicin - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IAC-VITA - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Lysine Acetylsalicylate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • MED-1101 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Stem Cell Therapy for Acute Myocardial Infarction - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Tribarcina - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • U-94 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Medestea Research & Production S.p.A. - Pipeline Analysis
    • Medestea Research & Production S.p.A. - Pipeline Products by Target
    • Medestea Research & Production S.p.A. - Pipeline Products by Route of Administration
    • Medestea Research & Production S.p.A. - Pipeline Products by Molecule Type
    • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action
  • Medestea Research & Production S.p.A. - Dormant Projects
  • Medestea Research & Production S.p.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Medestea Research & Production S.p.A., Key Facts
  • Medestea Research & Production S.p.A. - Pipeline by Indication, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2016
  • Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2016
  • Medestea Research & Production S.p.A. - Phase II, 2016
  • Medestea Research & Production S.p.A. - Phase I, 2016
  • Medestea Research & Production S.p.A. - Preclinical, 2016
  • Medestea Research & Production S.p.A. - Discovery, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Target, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2016
  • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2016
  • Medestea Research & Production S.p.A. - Dormant Developmental Projects,2016
  • Medestea Research & Production S.p.A., Other Locations

List of Figures

  • Medestea Research & Production S.p.A. - Pipeline by Top 10 Indication, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2016
  • Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Target, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2016
  • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2016
Back to Top